Cargando…
Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations
Cell-free DNA (cfDNA) analysis is a minimally invasive method that can be used to detect genomic abnormalities by directly testing a blood sample. This method is particularly useful for immunosuppressed patients, who are at high risk of complications from tissue biopsy. The cfDNA tumor fraction (TF)...
Autores principales: | Bouzidi, Amira, Labreche, Karim, Baron, Marine, Veyri, Marianne, Denis, Jérôme Alexandre, Touat, Mehdi, Sanson, Marc, Davi, Frédéric, Guillerm, Erell, Jouannet, Stéphanie, Charlotte, Frédéric, Bielle, Franck, Choquet, Sylvain, Boëlle, Pierre-Yves, Cadranel, Jacques, Leblond, Véronique, Autran, Brigitte, Lacorte, Jean-Marc, Spano, Jean-Philippe, Coulet, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369887/ https://www.ncbi.nlm.nih.gov/pubmed/34710202 http://dx.doi.org/10.3389/fcell.2021.661272 |
Ejemplares similares
-
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
por: Baron, Marine, et al.
Publicado: (2022) -
Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
por: Hernández-Verdin, Isaias, et al.
Publicado: (2022) -
Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy
por: Bertin, Lise, et al.
Publicado: (2021) -
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic
por: Benusiglio, Patrick R., et al.
Publicado: (2020) -
Prevalence of IGLV3-21(R110) among familial CLL: a retrospective study of 45 cases
por: Armand, Marine, et al.
Publicado: (2022)